Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Natrecor (nesiritide) in Transplant-Eligible Congestive Heart Failure
NCT00338455Phase 2Terminated
- Sponsor
- Scios Inc.
- Start
- Sep 2006
- Primary completion
- Oct 2007
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in heart failure (HF) comparing Nesiritide Arm with Placebo Arm (2 arms). Primary endpoint: Number of Days Alive Without Renal, Hemodynamic, or Electrical Clinical Worsening Through Day 28. Started Sep 2006; status: terminated.
02
Drugs
nesiritide
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on NCT00338455.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00338455.